Past Events


2018 Events

Global Cardio Oncology Summit



Nashville in October!

River View



Event Details

Date: October 15-16, 2015
Location: The Hilton Nashville Downtown
121 4th Avenue South
Nashville, TN 37201
United States


About this Year’s Conference

The first Global Cardio-Oncology Summit will be co-hosted by Dr. Susan Dent, Founder of the Canadian Cardiac Oncology Network (CCON) and Dr. Daniel Lenihan, President of the International CardiOncology Society (ICOS) North America.


This summit models a leading-edge interdisciplinary approach to preventative and targeted medicine in cardio-oncology. This important field of study, aimed at understanding cardiac complications of oncology treatments, has gained a growing interest from a number of healthcare providers including oncologists, cardiologists, radiologists, nurses, pharmacists, and basic scientists.


The Global Cardio-Oncology Summit will feature the latest research and clinical guidelines in the multidisciplinary field of cardio-oncology. We invite abstract submissions for the Global Cardio-Oncology Summit on the prevention, management and treatment of cardiac complications related to oncology therapy.


IMCO 2015IMCO 2015

International Meeting on CardiOncology

Towards A Comprehensive Cardica-Cancer Care

February 12-13, 2015

Hilton, Tel Aviv, Israel

CLICK HERE to learn more


For those who have an interest in the rapidly evolving field of cardio-oncology, we are pleased to invite you to an important meeting at ESC 2014 in Barcelona to discuss how we can work together to try to enhance clinical service, provide education and stimulate research in this new sub-specialty of medicine.


In particular, we would like to focus on:

  • Requirements for the development of a Cardio-Oncology Fellowship
  • Outline the scope and mission of a 501c3 designated non-profit research and educational society – The International CardiOncology Society-North America (ICOSNA).
  • Discuss the structure and goals/objectives of ICOS
  • Discuss how to enhance communication through social media – i.e web site, Facebook, Twitter, etc.

If you have important expertise about clinical practice, training and research in the area of cardio-oncology, please join us. We know there are many demands on your time; however, if you are attending ESC this year, we hope that you would consider attending this meeting at 8pm on Monday Sept. 1st, 2014 at:


La Fonda Del Port Olimpic


There will be a complete dinner with a set menu including wine/beer and short presentations to allow a template for open and invigorating discussion. Thanks for your interest and we hope to see you there!


Thanks for considering this invitation, and please RSVP by August 31, 2014 to John Fay,, or call/text to 813 810 7943 as to your attendance.




Event #14108

9-10 October 2014
Dorint Hotel Don Giovanni, Prague, Czech Republic


There is a tremendous amount of mechanistic overlap between targeted cancer therapy and cardiovascular tissues. Important drugs that may be active on cancer are increasingly likely to have significant collateral effects on cardiovascular structures. Understanding the underlying mechanisms and how to detect these problems early and manage them effectively can allow a critical drug for cancer efficacy to continue to develop as a clinical therapy. Additionally, tailoring the pharmacology of a potential cancer therapeutic based on known mechanistic insights is an essential area of preclinical development. Furthermore, enhancing interactions between cardiology and oncology at all levels of clinical trials allows for optimal patient outcomes.


Key Topics
• Best methods of cardiotoxicity detection during early phase clinical trials
• Best management approaches to protecting cardiac tissues during aggressive cancer therapy
• Known and theorised mechanistic actions of developing cancer therapy to allow cardioprotection
• Effective communication between drug developers and prescribers
• Optimal patient care between cardiology and oncology


Who Will Attend
• Cardiology, oncology and primary care physicians, nurse practioners, and other allied providers
• Drug development and clinical research managers and associates
• Pharmacovigilance, drug safety and drug surveillance personnel
• Pharmaceutical physicians and medical directors
• Safety pharmacology and non-clinical scientists
• Clinical pharmacology scientists
• Regulatory affairs officers
• Biostatisticians
• Data managers
• Outsourcing and marketing managers


The audience will include clinical research and industry experts including drug development scientists,
regulatory officials and academicians managing patients undergoing cancer therapy.

For more information please contact | +41 61 225 51 44

For a complete description of event click here: OCTOBER IN PRAGUE



Dr. Lenihan To Receive Twelfth Annual

 Enrique Lopez

Humanitarian and Cardiovascular Award

June 12th, 2014
Memorial Hospital of Tampa – Auditorium
2901 W Swann Ave
Tampa, FL 33609    MAP IT!

Dr. Daniel Lenihan is Director of Clinical Research Program at Vanderbilt University. He will be hosting a workshop and lecture as well as receiving the award.

9:30 a.m.  Workshop

12:00 p.m.  Lecture  (Topic: Cardiopathology)

CLICK  Enrique Lopez 2014 flyer TO DOWNLOAD FLYER



Event: The ICOSNA Dinner  Chicago

Host:  American Society of Clinical Oncology Conference

Date: June 2, 2014

Time: 6:30 pm til 9:00 p.m.

Attendees: Active Supporters & Members of ICOSNA

Location: The Hyatt McCormick Place
2233 S Dr Martin Luther King Jr Dr
Chicago, IL 60616    MAP IT!



4th Annual CCON Conference on CardiOncology

Date: May 8-9, 2014
Location:   Ottawa Convention Centre, 55 Colonel Drive, Ottawa, Ontario, K1N 9J2  MAP IT!

Ottowa3 About this Year’s Conference

The Canadian Cardiac Oncology Network (CCON) models a leading-edge interdisciplinary approach to preventative and targeted medicine in cardiac oncology. This important field of study, aimed at understanding cardiac complications of oncology treatments, has gained a growing interest from a number of healthcare providers including oncologists, cardiologists, radiologists, nurses, pharmacists, and basic scientists. The 4th Annual CCON Conference will feature the latest research and clinical guidelines in the multidisciplinary field of cardiac oncology. This conference is partnered with the Ottawa Heart Research Conference to co-host a plenary session on the latest in personalized medicine research in cancer and cardiovascular disease. For more information, please contact We look forward to meeting with you in May 2014!

Dr. Susan Dent CCON 2014 Co-Chair Medical Oncologist The Ottawa Hospital Cancer Centre Ottawa, Ontario, Canada
Dr. Christine Brezden-Masley CCON 2014 Co-Chair Medical Oncologist St. Michael’s Hospital Toronto, Ontario, Canada


2014 Conference Registration

To register for this year’s conference, please take a moment to download and fill out the Registration Form PDF. Once filled out and signed, please email the form to Registration Deadline: Friday, April 11, 2014 Submit an Abstract for the 4th Annual CCON Conference at: To submit an abstract for this year’s conference, please take a moment to download and fill out the Abstract Submission Form PDF, along with the Registration Form PDF above, and email both to Abstract Submission Deadline: Friday, April 4, 2014


Scientific Program

Thursday, May 8, 2014       7:30 – 22:00


7:30 – 8:15 Breakfast 1st Floor Atrium with OHRC
8:15 – 8:20 Introduction Co-Chairs: Dr. Susan Dent & Dr. Christine Brezden-Masley
8:20 – 8:30  Welcome Address Dr. Phil Wells, Senior Scientist, Clinical Epidemiology, Ottawa Hospital Research Institute; Professor, Chief & Chair, Department of Medicine, The Ottawa Hospital & University of Ottawa, Ottawa, ON

8:30 – 9:15 TBD.  Discussion: 15 minutes TBD   9:15 – 10:00 Cardio-Oncology: A New Platform for Basic and Translational Investigation.  Discussion: 15 minutes Dr. Javid Moslehi; Instructor, Department of Medicine, Harvard Medical School; Cardiologist, Brigham and Women’s Hospital, Boston, MA   10:00 – 10:15 Break 1st Floor Atrium with OHRC   10:15 – 11:10 CO-HOSTED PLENARY SESSION: Kinase inhibitors in cancer and the heart: Dealing with the other side of the coin.  Discussion: 15 minutes Dr. Thomas Force; Professor of Medicine, Clinical Director, Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA Room 201 with OHRC   11:10 – 12:00 DEBATE: Should preventative cardiac therapy (e.g. ACE inhibitors, beta blockers) be given to cancer patients with normal heart function before receiving potential cardiotoxic cancer therapy? Moderator: Dr. Michael Ewer.  Debaters: Dr. Jean-Bernard Durand & Dr. Sean Virani   12:00 – 13:00 Lunch 1st Floor Atrium with OHRC   13:00 – 13:45 Introduction to the NCI National Community Oncology Research Program: What does NCORP mean to CardioOncology?   Discussion: 15 minutes Dr. Michael Fisch; Chair, Department of General Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center Houston, TX   13:45 – 14:30 Echocardiography in the detection of cardiotoxicity.  Discussion: 15 minutes Dr. Rajeev Rao; Echocardiography Fellow, The University of Ottawa Heart Institute, Ottawa, ON   14:30 – 15:15 Role of cardiac MRI in the assessment of cardiotoxicity.  Discussion: 15 minutes Dr. Paaladinesh Thavendiranathan; Cardiologist, Toronto General Hospital, Toronto, ON   15:15 – 15:30 Break 1st Floor Atrium with OHRC   15:30 – 16:30 Abstract Oral Presentations: – Abstract #1 (20 minutes), – Abstract #2 (20 minutes), – Abstract #3 (20 minutes); Authors of Selected Abstracts   16:30 – 18:00 Poster Session & Networking Reception with OHRC/CCON Rideau Canal Atrium with OHRC   19:00 – 22:00 Optional Conference Dinner – RSVP Required Location TBD

Friday, May 9, 2014 7:30 – 15:30

7:30 – 8:00 Breakfast Rideau Canal South Atrium   8:00 – 9:00 Keynote Presentation: Risk of ischemic heart disease in women after radiotherapy for breast cancer. Discussion: 15 minutes Dr. Sarah Darby; Professor of Medicine Statistics, Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, England   9:00 – 9:45 Opportunities and challenges in cardio-oncology clinical research. Discussion: 15 minutes Dr. Edith Pituskin & Team; Assistant Clinical Professor, Radiation Oncology, University of Alberta, Cross Cancer Institute, Edmonton, AB   9:45 – 10:30 International CardiOncology Society: 2014 Update.  Discussion: 15 minutes Dr. Daniel Lenihan; Professor of Medicine; Director, Clinical Research Program, Vanderbilt Heart and Vascular Institute, Nashville, TN   10:30 – 10:45 Break Rideau Canal South Atrium   10:45 – 12:00 Case Studies.  Group Discussion Moderators: TBD   12:00 – 13:00 Lunch Rideau Canal South Atrium   13:00 – 14:15 Consensus Practice Guidelines. Group Discussion Moderators: TBD   14:15 – 14:45 National Cardiac Oncology Survey Results.  Discussion: 10 minutes Dr. Jeffrey Sulpher; Cardiac Oncology Fellow, The University of Ottawa & The Ottawa Hospital Cancer Centre, Ottawa, ON   14:45 – 15:15 Developing a Cardiac Oncology Fellowship Program.  Discussion: 10 minutes Dr. Gillian Murtagh; Cardiac Oncology Fellow, University of Chicago, Chicago, IL  

15:15 – 15:30 Closing Comments Co-Chairs: Dr. Susan Dent & Dr. Christine Brezden-Masley

***************************************************************************************************** SORRY, THIS EVENT HAS ALREADY OCCURRED: International Colloquium on Cardio-Oncology March 12-14, 2014 Hotel Columbus – Rome, Italy

The aim of this Colloquium is to provide an interactive forum on recent advances and future developments in Cardio-Oncology. Joseph R. Carver MD (University of Pennsylvania, Philadelphia) and Steven E. Lipshultz MD (University of Florida, Miami) will co-chair. Final Program and other Conference information are enclosed for your reading and free registration.   The International Colloquium on Cardio-Oncology will take place at the Columbus Hotel, near St. Peter’s square and once home of the cardinal who became Pope Julius II. The beautiful frescoes and paintings of this venue will add a touch of glamour to scientific agreements or controversies.   We have the pleasure to announce this International Colloquium on Cardio-Oncology and warmly invite you to attend it in a scenical and historical environment.   Colloquium Chair: Giorgio Minotti, MD – University Campus Bio-Medico of Rome Co-chairs: Joseph R. Carver MD, Steven E. Lipshultz MD Promoted by: Fondazione Internazionale Menarini